[go: up one dir, main page]

WO2002038126A3 - Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue - Google Patents

Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue Download PDF

Info

Publication number
WO2002038126A3
WO2002038126A3 PCT/DK2001/000715 DK0100715W WO0238126A3 WO 2002038126 A3 WO2002038126 A3 WO 2002038126A3 DK 0100715 W DK0100715 W DK 0100715W WO 0238126 A3 WO0238126 A3 WO 0238126A3
Authority
WO
WIPO (PCT)
Prior art keywords
particles
production
increased bioavailability
pharmaceutical compositions
hpmcas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2001/000715
Other languages
English (en)
Other versions
WO2002038126A2 (fr
Inventor
Ove Emil Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEA Aseptomag AG
Original Assignee
Aeromatic Fielder AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeromatic Fielder AG filed Critical Aeromatic Fielder AG
Priority to AU2002212102A priority Critical patent/AU2002212102A1/en
Publication of WO2002038126A2 publication Critical patent/WO2002038126A2/fr
Publication of WO2002038126A3 publication Critical patent/WO2002038126A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un procédé de production de particules pour une préparation pharmaceutique présentant une biodisponibilité accrue. Ce procédé comprend la vaporisation d'un noyau doté d'une solution ou d'une dispersion comprenant du succinate acétate hydroxypropylméthylcellulose (HPMCAS) et un composant actif pharmaceutique modérément soluble dans l'eau dans un liquide évaporable, l'évaporation du liquide afin d'obtenir un dépôt de HPMCAS et des composants actifs pharmaceutiques modérément solubles dans l'eau soluble, puis répétition du procédé jusqu'à l'obtention d'une taille ou d'un poids de particule prédéterminé.
PCT/DK2001/000715 2000-11-08 2001-10-29 Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue Ceased WO2002038126A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002212102A AU2002212102A1 (en) 2000-11-08 2001-10-29 A process for production of particles for pharmaceutical compositions having increased bioavailability

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70796600A 2000-11-08 2000-11-08
US09/707,966 2000-11-08

Publications (2)

Publication Number Publication Date
WO2002038126A2 WO2002038126A2 (fr) 2002-05-16
WO2002038126A3 true WO2002038126A3 (fr) 2002-10-10

Family

ID=24843867

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2001/000715 Ceased WO2002038126A2 (fr) 2000-11-08 2001-10-29 Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue

Country Status (2)

Country Link
AU (1) AU2002212102A1 (fr)
WO (1) WO2002038126A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103153343B (zh) * 2010-06-14 2015-02-11 陶氏环球技术有限责任公司 具有提高的醋酸酯和琥珀酸酯取代的醋酸羟丙基甲基纤维素琥珀酸酯
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
ATE409462T1 (de) * 2004-05-28 2008-10-15 Pfizer Prod Inc Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymer
AU2005258320B2 (en) 2004-06-24 2010-09-16 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
DK1993360T3 (en) 2005-12-28 2017-05-22 Vertex Pharma SOLID FORMS OF N- [2,4-BIS (1,1-DIMETHYLETHYL) -5-HYDROXYPHENYL] -1,4-DIHYDRO-4-OXOQUINOLIN-3-CARBOXAMIDE
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
CA2984994C (fr) 2009-03-20 2020-03-31 Vertex Pharmaceuticals Incorporated Procede pour preparer des modulateurs de regulateur de conductance transmembranaire de mucoviscidose
RU2692779C2 (ru) 2012-02-27 2019-06-27 Вертекс Фармасьютикалз Инкорпорейтед Фармацевтическая композиция и ее введения
KR20170063954A (ko) 2014-10-07 2017-06-08 버텍스 파마슈티칼스 인코포레이티드 낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0344603A1 (fr) * 1988-05-30 1989-12-06 Zeria Pharmaceutical Co., Ltd. Composition pharmaceutique contenant un dérivé de la dihydropyridine
WO1993000991A1 (fr) * 1991-07-03 1993-01-21 Smithkline Beecham Plc Procede de preparation de substances medicamenteuses sous forme de granules
WO1995020432A1 (fr) * 1994-01-27 1995-08-03 Aeromatic-Fielder Ag Dispositif d'enrobage de particules solides
EP0901786A2 (fr) * 1997-08-11 1999-03-17 Pfizer Products Inc. Dispersions solides pharmaceutiques à biodisponibilité accrue
US5985322A (en) * 1997-05-29 1999-11-16 Eli Lilly And Company Method for the treatment of CNS disorders
WO2000040339A1 (fr) * 1998-12-30 2000-07-13 Aeromatic-Fielder Ag Appareil et procede d'enrobage de comprimes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0344603A1 (fr) * 1988-05-30 1989-12-06 Zeria Pharmaceutical Co., Ltd. Composition pharmaceutique contenant un dérivé de la dihydropyridine
WO1993000991A1 (fr) * 1991-07-03 1993-01-21 Smithkline Beecham Plc Procede de preparation de substances medicamenteuses sous forme de granules
WO1995020432A1 (fr) * 1994-01-27 1995-08-03 Aeromatic-Fielder Ag Dispositif d'enrobage de particules solides
US5985322A (en) * 1997-05-29 1999-11-16 Eli Lilly And Company Method for the treatment of CNS disorders
EP0901786A2 (fr) * 1997-08-11 1999-03-17 Pfizer Products Inc. Dispersions solides pharmaceutiques à biodisponibilité accrue
WO2000040339A1 (fr) * 1998-12-30 2000-07-13 Aeromatic-Fielder Ag Appareil et procede d'enrobage de comprimes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103153343B (zh) * 2010-06-14 2015-02-11 陶氏环球技术有限责任公司 具有提高的醋酸酯和琥珀酸酯取代的醋酸羟丙基甲基纤维素琥珀酸酯
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces

Also Published As

Publication number Publication date
AU2002212102A1 (en) 2002-05-21
WO2002038126A2 (fr) 2002-05-16

Similar Documents

Publication Publication Date Title
WO2002038126A3 (fr) Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue
WO2004012699A3 (fr) Nouveau systeme d'administration de medicaments
WO2003043574A3 (fr) Compositions pharmaceutiques sous forme particulaire
WO2002101412A3 (fr) Compositions lyophilisees de pulverisation
WO2003035051A3 (fr) Utilisation d'agents sequestrants des protons dans des formulations medicamenteuses
WO2004098561A3 (fr) Materiaux particulaires
WO2001078689A3 (fr) Composition particulaire
WO2002043702A3 (fr) Compositions pharmaceutiques pour inhalation
WO2004012700A3 (fr) Nouvelle forme galenique
WO2002082902A3 (fr) Formulation granulaire concentree soluble dans l'eau regulatrice de la croissance des plantes et procedes d'utilisation
AU2001262011A1 (en) A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component
WO2005025535A3 (fr) Procedes de preparation de compositions pharmaceutiques
WO2002003914A3 (fr) Formulations ameliorees d'hormones thyroidiennes
CA2514446A1 (fr) Composition comprenant un melange de principes actifs et methode pour la preparer
NO331256B1 (no) Fremgangsmate for fremstilling av granuler med maskert smak og umiddelbar frigjoring av det aktive prinsipp
AU2003291973A1 (en) A self-cleaning spray nozzle
NZ527585A (en) Tablets quickly disintegrated in oral cavity
WO2005079755A3 (fr) Poudres antagonistes de l'interleukine-13, particules sechees par pulverisation, et procedes
WO2001037816A3 (fr) Enrobage
GR3023242T3 (en) Process for the preparation of solid sustained release pharmaceutical forms
EP1238662A3 (fr) Procédé de fabrication de granules d' un médicament, les granules du médicament et des préparations pharmaceutiques contenant ces granules
CA2356959A1 (fr) Systeme de distribution de medicament insoluble dans l'eau
WO2006089674A3 (fr) Comprimés présentant une dispersibilité de substance médicamenteuse améliorée
WO2004017943A3 (fr) Formulations lipidiques cationiques non vesiculaires
CA2390746A1 (fr) Composition pharmaceutique a bse de derives de quinolinone et methode pour sa production

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP